EMLA Cream Application without Occlusive Dressing before Upper Facial Botulinum Toxin Injection A Randomized, Double-Blind, Placebo-Controlled Trial
|
|
- Nancy Wiggins
- 5 years ago
- Views:
Transcription
1 Bahmani-Kashkouli et al EMLA Cream and Botulinum Toxin Iranian Journal of Ophthalmology - Volume 19, Number 4, 2007 EMLA Cream Application without Occlusive Dressing before Upper Facial Botulinum Toxin Injection A Randomized, Double-Blind, Placebo-Controlled Trial Mohsen Bahmani-Kashkouli, MD, 1 Shabnam Salimi, MD 2 Pejman Bakhtiari, MD, 3 Mostafa Soltan-Sanjari, MD 3 Abstract Purpose: To assess the effect of EMLA cream application without occlusive dressing on pain on needling (PN) and pain on injection (PI) felt during multiple botulinum toxin type A (BTA) injections for correction of hyperkinetic upper facial lines Methods: A Prospective, randomized, double-blind, placebo-controlled clinical trial was conducted on 44 subjects seeking upper facial wrinkles correction. Either EMLA or placebo cream without occlusive dressing was applied on each side of the upper face at least for 60 minutes prior to injections of BTA. PN and PI scores were measured with Visual Analog Scale (VAS). Results: Patients age ranged from 27 to 57 (mean=40.95) years. Mean PN score (3.46) was less than PI score (3.61) (non significant); the two scores were highly correlated (r: 0.63, P=0.000). While both PN and PI scores were less in the EMLA (3.02 and 3.34, respectively) than those of placebo group (3.90 and 3.89, respectively), the difference was statistically significant only for PN score (P=0.000 for PN and P=0.06 for PI). Male subjects had less PN and PI scores than females which was not statistically significant (P=0.66 for PN and 0.63 for PI). Time intervals between the cream application and BTA injections (60 to 110 minutes; mean=73.02, SD=10.15) did not have significant effect on the pain scores. Conclusion: EMLA cream application without occlusive dressing significantly reduces PN associated with multiple BTA injections. Reduction of PI was not significant. Longer duration of EMLA cream application (up to 110 minutes) did not show lower pain score in either type of the pain. Keywords: EMLA cream, botulinum toxin, facial lines, pain, pain control Iranian Journal of Ophthalmology 2007;19(4): Associate Prof. of Ophthalmology, Oculoplastic Service, Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences 2. Researcher, Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences 3. Assistant Prof. of Ophthalmology, Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences Received: May 28, 2006 Accepted: February 8, 2007 Correspondence to: Mohsen Bahmani-Kashkouli, MD Eye Research Center Rassoul Akram Hospital Tel: bahmanik@yahoo.com 28
2 Introduction Botulinum toxin type A (BTA) is produced by Clostridium botulinum and causes a reversible, selective muscle relaxation that leads to a temporary flattening of the mechanical component of the wrinkling without the stigmata of invasive surgery. It is now widely used to correct hyperkinetic facial lines especially in the upper third of the face around the eyes and eyebrows such as frown lines, forehead creases, and crow s feet. The injections need to be repeated because the effect lasts only for a few months. The most common adverse effects are pain and hematoma. 1 The pain felt by the patients during multiple BTA injections may be at times become so distressing that lead to occasional interruption during a treatment or deter some patients from seeking further treatment. This problem is further intensified in patients who have needle phobia. This pain could be due to skin puncturing with a needle (pain on needling, PN) or skin stretching related to the injection of BTA (pain on injection, PI). There are some methods developed to reduce the pain during BTA injection such as using preservative-containing saline solutions that contain benzyl alcohol 2 and skin cooling 3,4 before injection. Lidocaine tape 5 and EMLA cream 6 have also been used with a significant effect to reduce the pain due to the BTA injection in patients with facial dyskinesia. EMLA cream has been shown to reduce the pain associated with skin puncturing and other superficial skin procedures in both children and adults. 7-9 It is applied under an occlusive dressing. 6-9 Based on our previous experience with EMLA cream application in subjects who were seeking facial cosmetic BTA injections, there are three problems complained by these subjects: the first was that not all of the subjects felt the same about its pain reducing effect, the second problem was the longevity of its application before BTA injections which was time consuming, and the third was that almost all of them were unhappy with the occlusive dressing. This study aimed to investigate the effects of EMLA cream application without occlusive dressing on both PN and PI felt during multiple BTA injections for correction of hyperkinetic upper facial lines and assess the correlation between PN and PI. A new technique of separate needle injection is also 29 introduced to possibly increase ease of multiple skin needling. To the best of our knowledge, this is the first clinical trial assessing the effect of EMLA cream application on different pains felt during multiple BTA injections for correction of hyperkinetic facial lines and also the first study assessing its effect without occlusive dressing. Methods A prospective, randomized, double-blind, placebo-controlled clinical trial was performed. Our institutional ethics committee approved the study and informed consent was obtained from 44 consecutive subjects who were seeking for correction of hyperkinetic facial wrinkles on the upper face including the forehead, lateral orbital, and glabellar regions. All the BTA injections were performed in a private practice setting by an oculoplastic surgeon (MBK) from July to December Difference between the scores of the two groups estimated as 1.5, σ as 1.9, and a 5% α error, two sided required sample size was 44 with 80% power. 10 Subjects with systemic conditions requiring the regular use of analgesics or anxiolytics, those with a known sensitivity to local anesthetics, those with previous facial surgery or trauma, subjects with medical, psychological, or social conditions predisposing to a different perception of pain, and subjects who needed different number and amount of BTA injections on two sides of the face were excluded. Cream application Subjects were randomly (table of random digits) allocated to have EMLA cream (eutectic mixture of 2.5% lidocaine and 2.5% prilocaine, Tehran Chemie Ltd, Tehran, Iran) application on either the right or left side of the upper face. They were coded and secured by a trained staff. A thick layer of EMLA cream was placed on one half of the face and Vaseline cream (Tolidarou Ltd, Tehran, Iran), as placebo, was placed on the other half of the upper face. It was applied by a trained staff at least 60 minutes before BTA injection. The creams were kept out of the periocular area by applying them no closer than the bony orbital rims. Demographics data were
3 recorded and the Visual analog scale (VAS) was explained to the subjects while they were waiting. They were asked if they had previous BTA injection at the same facial area, too. The creams were gently wiped off with 4x4 gauzes at time intervals after 60 minutes just before sending the subjects for the injections. Staff who applied the creams also randomly (table of random digits) determined which side of the face was to be injected first. BTA injection The skin was sterilized with alcohol in the injection room. BTA, Dysport (500 units, Ipsen Ltd, Berkshire, UK) was used in this study. It was diluted with normal saline totally in 2.5 ml, leading to 20 units BTA per 0.1 ml. The injections were administered by a 1-ml, 27- gauge, 13-mm-long disposable needle syringe (Supa, Tehran, Iran). Regarding the injections either with EMLA or placebo, the samevolume and equal dose of BTA was given to each side of the face in each subject. A larger volume and more injections were given in males. Ten to twenty units of BTA per site ( ml) was injected, distributed over 2-3 injection points at the area of crow s feet, 2-3 at the forehead creases, and 2 at the glabellar area in each side of the face. Intensity of the pain on puncturing the skin and during injections were assessed immediately after the injection at each side using a VAS (0= no pain, 10= maximal pain). Subjects were asked to put a cross on the 0-10 VAS both for PN and PI after finishing each side. They were also asked to compare the overall pain felt during the injections at each side with the previous injections. These data were recorded in a special form. A new needle was used at each side of the face. The nasal bridge point of injection for procerus muscle was given after completion of injections and marking the VAS on both sides. Completed forms and data regarding subject s codes were separately given to the statisticians. Data was analysed using the software SPSS MS Window Release 11.0, Chicago. Pearson correlation test was used to assess the correlation of PN and PI with age and duration of cream application. It was also used to assess the correlation between PN and PI. Sample K-S test was used to find the type of distribution of the pain among responders. Independent sample t test was used to compare the PN and PI scores between males and females. Paired samples t test was used to compare pain scores between case and control groups as well as the effect of starting side of injection on the pain scores. Results Forty-four subjects, of which 5 (11.40%) were males, were studied. Age ranged from 27 to 57 years (mean=40.95 SD=7.65). There was at least one previous injection of BTA without using any pain reducing method in 16 (36.40%) patients. Time intervals between the cream application and BTA injections were 60 to 110 minutes (mean=73.02, SD=10.15). Male subjects had less PN (mean=2.82, SD=2.30) and PI (mean=2.92, SD=1.60) scores than female (mean=3.24, SD=2.02 for PN and mean=3.38, SD=2.12 for PI). This difference was however not statistically significant (P=0.66 for PN and 0.63 for PI scores). Mean PN score (3.46±2.11, 0.1 to 8.5) was less than PI score (3.61±2.34, 0 to 9.1). However, there was a significant correlation and no difference between PN and PI scores (Table 1). Age and duration of EMLA cream application (range, minutes) did not demonstrate a statistically significant correlation with PN and PI scores (Table 1). One-sample K-S test showed a normal distribution for both PN and PI scores. While both PN and PI scores were less in the EMLA than placebo group, the difference was only statistically significant for PN score (Table 2). Starting the injection from the EMLA cream side or placebo side did not have any significant impact on the pain scores (PN and PI) (0.22<P<0.86). Sixteen subjects compared their overall pain with their previous experiences with BTA injections for upper facial wrinkles (Table 3). No significant local side effects of EMLA cream such as erythema, scaling, edema, and conjunctival congestion were noted. There was one subject who developed a minimal unilateral ptosis which was disappeared in 2 weeks time. 30
4 Table 1. Correlation of pain scores, age, and duration of EMLA cream application in 44 subjects undergoing multiple botulinum toxin type A injections for upper facial wrinkles. Scores are based on Visual Analog Scale measured from 1 to Pain on needling score 3.46±2.11 Pain on needling score 3.46±2.11 N/A Age (27-57 years) Duration of EMLA cream application ( min) r: 0.04 P=0.77 r: 0.01 P=0.89 Pain on injection score 3.61±2.34 r: 0.63 P=0.000 r: 0.08 P=0.60 r: 0.05 P=0.58 Table 2. Mean pain scores felt by subjects undergoing multiple botulinum toxin type A injections for upper facial wrinkles. Scores are based on Visual Analog Scale measured from 1 to 10. EMLA cream side Placebo side Paired-Sample t test Mean pain on needling score 3.02 (SD=2.12) 3.90 (SD=2.02) Mean pain on injection score 3.34 (SD=2.25) 3.89 (SD=2.43) P= % CI; to P= % CI; to 3.38 Table 3. Comparison of pain on each side of the face to pain on previous injections of botulinum toxin type A for the correction of upper facial wrinkles in 16 subjects Equal pain More pain Less pain EMLA cream group 5 (31.25%) 2 (12.5%) 9 (56.25%) Placebo group 10 (62.5%) 2 (12.5%) 4 (25%) Discussion The pain problem and accompanying distressing period are still a significant problem that needs to be overcome both by doctor and patient. In patients who have needle phobia, distressing processes are further intensified. Multiple BTA injections can be associated with significant pain due to both needle insertion and stretching related to the toxin injection. Kristan and Stasior 11 reported an incidence of 100% pain associated with BTA injection for patients with blepharospasm. Van Laborde et al 2 proposed diluting the BTA with benzyl alcohol containing preservative saline and found a 32% reduction of pain. They also noted that diluting toxin with lidocaine and epinephrine did not reduce the effectiveness of the drug and caused less pain during injection. 12,13 Ice application can significantly reduce the pain associated with BTA injection. 3,4 EMLA (eutectic mixture of local anesthetics) cream is an oil-water emulsion of lidocaine and prilocaine. The mixture is termed eutectic, because the crystalline bases mix to create lower melting points than what would be achieved individually, creating ideal circumstances for skin penetration. 9 Analgesia of the skin is achieved by the release of lidocaine and prilocaine from the cream into the cutaneous and subcutaneous nociceptors and free nerve endings. 14 EMLA has been shown to reduce the pain associated with skin puncturing and other superficial skin procedures in both children and adults. 7-9 Kuwahara and Skinner 15 compared ice and EMLA prior to injection of a 30-guage needle containing a painful stimulus and stated that although both decrease the discomfort, EMLA performed significantly better in pain control than ice. Soylev and associates 6 used EMLA cream for 17 patients with facial
5 dyskinesia and concluded that it is significantly effective method to decrease the pain. Gotsis et al 8 used EMLA cream to anesthetize the eyelid for some eyelid skin surgeries and found excellent results in 76.3% (29/38) of cases. All of the investigators used EMLA cream under an occlusive dressing. We achieved a significant reduction of PN with at least a 60-minute application of a thick layer of EMLA cream without occlusive dressing before multiple BTA injections over the upper face area. Whereas, pain on injection was not reduced to a statistically significant degree. Bjerring and Arendt-Nielsen 16 studied the depth and duration of analgesia during needle insertion after the application of EMLA cream on the forearm. They found several factors influenced the depth and duration of analgesia including cutaneous blood flow, epidermal thickness, history of atopic dermatitis, and diffusion after the cream has been removed. There has been no study assessing the PI score alone after EMLA cream application for BTA injections. Tatsuya et al. 5 however used lidocaine tape on the eyelid skin before BTA injection for patients with Meige syndrome and found significantly less PN and PI in the case than control group. We applied EMLA cream without occlusive dressing on the upper face skin excluding eyelid. Although results showed less PI in the EMLA group, it was not statistically significant. Thicker skin in the upper face comparing to the eyelid and/or absence of an occlusive dressing might account for the ineffectiveness of the EMLA cream on PI. A comparative trial of EMLA cream application with and without the occlusive dressing before multiple BTA injections would clarify if occlusive dressing has a better effect on PI. Kuvaki et al 17 used EMLA cream to assess the pain of retrobulbar injection and reported no difference between EMLA and control group. They stated that ineffectiveness of EMLA cream should be considered for deep injections. 17 Our results showed that a longer duration of EMLA cream application (up to 110 minutes) did not reduce the pain score in either type of the pain (Table 1). There was a high correlation and no significant difference between the PN and PI (Table 1). While mean score of PI was more than PN in both EMLA and placebo group (Table 2); this difference did not reach significance. We assumed that starting the injections on the EMLA or placebo side might result in a different feeling of the pain. Some subjects might experience more pain on the second side due to lower threshold after repeated injections on the first side. On the other hand, it could be reverse. Expectedness of the pain on the second side injections might reduce feeling of the pain. Therefore, the side of first injections was randomly determined by our staff. The pain scores (PN and PI) were analyzed in these two groups and found to be no different. EMLA cream is highly alkaline and can be particularly toxic to the eye. 18 While it frequently causes blanching of the skin, 19 skin hyperpigmentation 20 has also been reported. However, no significant local side effects of EMLA cream such as erythema, scaling, edema, hypo- or hyperpigmentation, and conjunctival congestion were noted in this series. Multiple skin puncturing with one needle may gradually increase the pain on needling on the second side of the face because of dulling of the needle. Thus, we routinely use two needles for two sides of the face and feel the skin puncturing is much easier. It however is not clear whether in practice it benefits the patients as well. Subjects compared their pain during the recent BTA injections with the same injections they had previously without any pain reducing application. Almost one-third (5/16) of the responders felt the same pain as previous injections in the EMLA group. One-fourth of the responders felt less pain than previous injections in the placebo group (Table 3). Parallel to our previous experiences, results show that EMLA cream is useful for some but not all subjects seeking multiple BTA injections for hyperkinetic facial lines. Measuring fear of injection scores preoperatively would help to assess which group of patients might benefit most from any measure of reducing pain associated with multiple BTA injections. We did not measure a fear of injection score preoperatively which could be a subject for future research. 32
6 Conclusion Simple use and particularly minimization of patient discomfort makes EMLA cream application without occlusive dressing a recommendable option in multiple BTA injections. This is especially worthwhile when multiple injections are given to subjects who have needle phobia and psychological References distress because of injections. These subjects could be educated how to apply the cream at home to save time. Using separate needle for each side of the face may increase the ease of skin puncturing and reduce pain on needling as well. 1. Wollina U, Konrad H. Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures. Am J Clin Dermatol 2005;6: Van Laborde S, Dover JS, Moore M, Stewart B, et al. Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: a double-blind, randomized controlled trial. J Am Acad Dermatol 2003;48: Linder JS, Edmonson BC, Laquis SJ, Drewry RD Jr, et al. Skin cooling before periocular botulinum toxin A injection. Ophthal Plast Reconstr Surg 2002;18: Sarifakioglu N, Sarifakioglu E. Evaluating the effects of ice application on the pain felt during botulinum toxin type-a injections: a prospective, randomized, single-blind controlled trial. Ann Plast Surg 2004;53: Onguchi T, Takano Y, Dogru M, Ono M, et al. Lidocaine tape (Penles) reduces the pain of botulinum toxin injection for Meige syndrome. Am J Ophthalmol 2004;138: Soylev MF, Kocak N, Kuvaki B, Ozkan SB, et al. Anesthesia with EMLA cream for botulinum A toxin injection into eyelids. Ophthalmologica 2002;216: Smith M, Gray BM, Ingram S, Jewkes DA. Double-blind comparison of topical lignocaine-prilocaine cream (EMLA) and lignocaine infiltration for arterial cannulation in adults. Br J Anaesth 1990;65: Gotsis SS, Volonaki OM, Theodossiadis GP. Percutaneous anaesthesia with a lignocaine-prilocaine cream (Emla) for eyelid skin surgery. Br J Ophthalmol Mar;78(3): Rogers TL, Ostrow CL. The use of EMLA cream to decrease venipuncture pain in children. J Pediatr Nurs 2004;19: Parametric sampling: Z and t tests. In: Feinstein AR. Principles of medical statistics. New York: Chapman & Hall/CRC,2001; Kristan RW, Stasior OG. Treatment of blepharospasm with high dose brow injection of botulinum toxin. Ophthal Plast Reconstr Surg 1987;3: Gassner HG, Sherris DA. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study. Mayo Clin Proc 2000;75: Blitzer A, Binder WJ, Aviv JE, Keen MS, et al. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 1997;123: Egekvist H, Bjerring P. Effect of EMLA cream on skin thickness and subcutaneous venous diameter. A randomized, placebo-controlled study in children. Acta Derm Venereol 2000;80: Kuwahara RT, Skinner RB. Emla versus ice as a topical anesthetic. Dermatol Surg 2001;27: Bjerring P, Arendt-Nielsen L. Depth and duration of skin analgesia to needle insertion after topical application of EMLA cream. Br J Anaesth 1990;64: Kuvaki B, Gokmen N, Gunenc F, Ceyhan Kara H, et al. EMLA does not permit pain-free retrobulbar injection. Acta Anaesthesiol Scand 2003;47: Eaglstein NF. Chemical injury to the eye from EMLA cream during erbium laser resurfacing. Dermatol Surg. 1999;25: Bjerring P, Andersen PH, Arendt-Nielsen L. Vascular response of human skin after analgesia with EMLA cream. Br J Anaesth 1989;63: Godwin Y, Brotherston M. Hyperpigmentation following the use of Emla cream. Br J Plast Surg 2001;54:
DEPTH AND DURATION OF SKIN ANALGESIA TO NEEDLE INSERTION AFTER TOPICAL APPLICATION OF EMLA CREAM
British Journal of Anaesthesia 1990; 64: 173-177 DEPTH AND DURATION OF SKIN ANALGESIA TO NEEDLE INSERTION AFTER TOPICAL APPLICATION OF EMLA CREAM P. BJERRING AND L. ARENDT-NIELSEN SUMMARY We have determined
More informationProtocol. Title: The Effect of Needle Size on Pain Perception in Patients Treated with Botulinum Toxin A Injections
Protocol Title: The Effect of Needle Size on Pain Perception in Patients Treated with Botulinum Toxin A Injections Principal Investigator: Murad Alam, MD 1 Table of contents Table of contents List of abbreviations
More informationReduction of Pain and Anxiety Prior to Botulinum Toxin Injections With a New Topical Anesthetic Method
ORIGINAL ARTICLE Reduction of Pain and Anxiety Prior to Botulinum Toxin Injections With a New Topical Anesthetic Method Richard A. Weiss, M.D.*, and Phillip T. Lavin, M.D., Ph.D. *Weiss Cosmetic and Laser
More informationTopical EMLA Cream as a Pretreatment for Facial Lacerations
Topical EMLA Cream as a Pretreatment for Facial Lacerations Original Article Sung Woo Park, Tae Suk Oh, Jong Woo Choi, Jin Sup Eom, Joon Pio Hong, Kyung S Koh, Taik Jong Lee, Eun Key Kim Department of
More informationThe Effects of Nursing Intervention on Pain Control during Chemoport Needle Insertion
Vol.128 (Healthcare and Nursing 2016), pp.169-173 http://dx.doi.org/10.14257/astl.2016. The Effects of Nursing Intervention on Pain Control during Chemoport Needle Insertion Jin Hee Shin 1, Mee Lan Park²,
More informationThe Effect of Microneedle Thickness on Pain During Minimally Invasive Facial Procedures: A Clinical Study
532941AESXXX10.1177/1090820X14532941Aesthetic Surgery JournalSezgin et al research-article2014 INTERNATIONAL CONTRIBUTION Cosmetic Medicine The Effect of Microneedle Thickness on Pain During Minimally
More informationEFFICACY OF EUTECTIC MIXTURE OF LIGNOCAINE AND PRILOCAINE IN CLOSED REDUCTION OF NASAL FRACTURES
Acta Biomedica Scientia e - ISSN - 2348-2168 Print ISSN - 2348-215X www.mcmed.us/journal/abs Research Article EFFICACY OF EUTECTIC MIXTURE OF LIGNOCAINE AND PRILOCAINE IN CLOSED REDUCTION OF NASAL FRACTURES
More informationSurgical Correction of Crow s Feet Deformity With Radiofrequency Current
INTERNATIONAL CONTRIBUTION Oculoplastic Surgery Surgical Correction of Crow s Feet Deformity With Radiofrequency Current Min-Hee Ryu, MD; David Kahng, MD; and Yongho Shin, MD, PhD Aesthetic Surgery Journal
More informationEffect of Topical Anesthetics on Needle Insertion Pain During Botulinum Toxin Type A Injections for Limb Spasticity
ORIGINAL ARTICLE Effect of Topical Anesthetics on Needle Insertion Pain During Botulinum Toxin Type A Injections for Limb Spasticity Sharon Fung, MD, Chetan P. Phadke, PhD, Alice Kam, MD, Farooq Ismail,
More informationNew Medicines Profile
New Medicines Profile August 2008 Issue. 08/07 Lidocaine 70mg/tetracaine 70mg medicated plaster (Rapydan ) Concise evaluated information to support the managed entry of new medicines in the NHS Summary
More informationAnesthesia and Analgesia
Chapter 4 Anesthesia and Analgesia M. de Maio 4 Contents 4.1 Introduction................ 23 4.2 Preoperative Evaluation......... 23 4.3 Local Anesthesia............. 24 4.4 Topical Anesthesia............
More informationIsaac Wiebe Medical Student C W Wiebe Medical Centre June & July 2015
Isaac Wiebe Medical Student C W Wiebe Medical Centre June & July 2015 Needlestick procedures Many interventions rely on needlestick procedures Venipuncture, intravenous cannulation, vaccination, lumbar
More informationThe eutectic mixture local anesthetics (EMLA) cream is more effective on venipuncture pain compared with lidocaine tape in the same patients
Matsumoto et al. JA Clinical Reports (2018) 4:73 https://doi.org/10.1186/s40981-018-0210-1 CLINICAL RESEARCH ARTICLE Open Access The eutectic mixture local anesthetics (EMLA) cream is more effective on
More informationEfficacy of the Valsalva Maneuver on Needle Projection Pain and Hemodynamic Responses During Spinal Puncture
156 Research Paper International Journal of Medical Sciences 2011; 8(2):156-160 Ivyspring International Publisher. All rights reserved. Efficacy of the Valsalva Maneuver on Needle Projection Pain and Hemodynamic
More informationcally, a distinct superior crease of the forehead marks this spot. The hairline and
4 Forehead The anatomical boundaries of the forehead unit are the natural hairline (in patients without alopecia), the zygomatic arch, the lower border of the eyebrows, and the nasal root (Fig. 4.1). The
More informationBotulinum Toxin
Botulinum Toxin Botulinum toxin type A injections are one of the most popular minimally-invasive cosmetic procedures performed to treat facial lines and wrinkles, called frown lines, on the forehead. Botulinum
More informationCosmetic Oculofacial Applications of Botulinum Toxin
Ophthalmic Technology Assessment Cosmetic Oculofacial Applications of Botulinum Toxin A Report by the American Academy of Ophthalmology Sara A. Kaltreider, MD, Robert H. Kennedy, MD, PhD, John J. Woog,
More informationBotulinum Toxin Application
Botulinum Toxin Application Clostridium botulinum: rod-shaped bacterium producing the neurotoxin botulin Gram-positive anaerobic bacterium Seven serotypes - A, B, C, D, E, F, G http://standeyo.com/news/08_health/081202.biological.weapons.html
More informationBotox pearls, perils, and pitfalls. Patient comfort. Patient comfort. Higher doses give longer results. Botox (onabotulinumtoxina) starting doses
Botox pearls, perils, and pitfalls Ronald L. Moy, M.D, Beverly Hills, CA No financial conflicts of interests. Botox before Botox after Risks, rewards, happy, unhappy- higher doses, fewer injection sites,
More informationEffectiveness of Topical Lidocaine-Prilocaine Cream for Pain Control During Femoral Artery Catheterization in Adult Patients: a Prospective Study
Effectiveness of Topical Lidocaine-Prilocaine Cream for Pain Control During Femoral Artery Catheterization in Adult Patients: a Prospective Study Adnan I. Qureshi, MD 1, Muhammad A. Saleem, MD 1,2 *, Nishath
More informationExternal lacrimal punctum grading: Reliability and interobserver variation
European Journal of Ophthalmology / Vol. 18 no. 4, 2008 / pp. 507-511 External lacrimal punctum grading: Reliability and interobserver variation M.B. KASHKOULI 1, N. NILFORUSHAN 1, M. NOJOMI 2, R. REZAEE
More informationRegional nerve block of the upper eyelid in oculoplastic surg e r y
E u ropean Journal of Ophthalmology / Vol. 16 no. 4, 2006 / pp. 5 0 9-5 1 3 Regional nerve block of the upper eyelid in oculoplastic surg e r y A.R. ISMAIL, T. ANTHONY, D.J. MORDANT, H. MacLEAN Portsmouth
More informationInformed Consent Botulina Toxins Botox, Dysport, Xeomin Neurotoxins
Informed Consent Botulina Toxins - Botox Neurotoxins Informed Consent Botulina Toxins Botox, Dysport, Xeomin Neurotoxins INSTRUCTIONS This is an informed-consent document that has been prepared to help
More informationBotulinum toxin: Getting started with cosmetic treatment Learning Objectives The Aging Face The Aging Face The Aging Face
1 2 Botulinum toxin: Getting started with cosmetic treatment Suzanne K. Freitag, M.D. Director, Ophthalmic Plastic Surgery Service Massachusetts Eye and Ear Infirmary Harvard Medical School 3 I have no
More informationBotulinum Toxin Dosage Template for Frontal Wrinkle Effacement
INTERNATIONAL CONTRIBUTION Cosmetic Medicine Botulinum Toxin Dosage Template for Frontal Wrinkle Effacement Ivo Sternick, MD; and Ivo Pitanguy, MD Since the first report in the early 1970s, 1 several studies
More informationNonablative Infrared Skin Tightening in Type IV to V Asian Skin: A Prospective Clinical Study
Nonablative Infrared Skin Tightening in Type IV to V Asian Skin: A Prospective Clinical Study SZE-HON CHUA, FRCP (EDIN), POR ANG, MRCP (UK), y LAWRENCE S. W. KHOO, MRCP (UK), y AND CHEE-LEOK GOH, FRCP
More informationMicroneedling Therapy in Atrophic Facial Scars: An Objective Assessment
ORIGINAL ARTICLE Microneedling Therapy in Atrophic Facial Scars: An Objective Assessment Background: Atrophic facial scars are always a challenge to treat, especially the ones that are deep-seated and/or
More informationFrequently Asked Questions
Frequently Asked Questions What are the causes of wrinkles and facial expression lines? As noted above, lines and wrinkles develop, at least in part, from the action of facial muscles under the skin. After
More informationAL-AZHAR ASSIUT MEDICAL JOURNAL
TOPICAL LIDOCAINE-PRILOCAINE CREAM (EMLA) VERSUS MEPIVACAINE INFILTRATION FOR REDUCING PAIN DURING REPAIR OF MEDIOLATERAL EPISIOTOMY AFTER SPONTANEOUS VAGINAL DELIVERY Hossam M Abdelnaby and Ahmed Mahmoud
More informationALTERNATIVE TREATMENTS
Botox Consent INSTRUCTIONS This is an informed- consent document which has been prepared to help your plastic surgeon inform you concerning BOTOX (Botulina Toxin Type A, Allergan) injection, its risks,
More informationMULLERS MUSCLE-CONJUNCTIVAL RESECTION PTOSIS PROCEDURE
Australian and New Zealand Journal of Ouhthalmology 1985; 13: 179-183 MULLERS MUSCLE-CONJUNCTIVAL RESECTION PTOSIS PROCEDURE ALLEN M. PUTTERMAN MD University Of lll~nois Eye and Ear Infirmary, Michael
More informationP atients seeking facial rejuvenation
By Hema Sundaram, MD A Practical Primer For Dysport, Part 2: Strategies for Success with the Periorbital Frame and Special Considerations for Skin of Color Comprehensive patient assessment, a thorough
More informationSEE IMPORTANT SAFETY INFORMATION ON PAGE 2. See Important Safety Information inside.
See Important Safety Information inside. Visit BotoxCosmetic.com to learn more. By prescription only. 1-800-BOTOX-MD Also from the Allergan family of brands: 2010 Allergan, Inc., Irvine, CA 92612. marks
More informationTopical Local Anaesthesia
Topical Local Anaesthesia Comfort Kids Program 2017 Topical Local Anaesthesia (LA) How does topical LA cream works Misconceptions Cautions Preparation Application Alternatives Dosage Documentation Basic
More informationBotulinum Toxin A: A Review of 1,085 Oral and Maxillofacial Patient Treatments
J Oral Maxillofac Surg 61:317-324, 2003 Botulinum Toxin A: A Review of 1,085 Oral and Maxillofacial Patient Treatments Joseph Niamtu III, DDS* Purpose: Botulinum toxin A (Botox; Allergan, Inc, Irvine,
More informationPRE- READING COURSE MATERIAL ADVANCED BOTOX Module 2
PRE- READING COURSE MATERIAL ADVANCED BOTOX Module 2 Unit Overview Storage and shelf-life Cautions and contra-indications of treatment Reconstitution The treatment process Cosmetic indications for use
More informationSingle Injection versus Double Injection Peribulbar Anaesthesia in Eye Camp Surgery: a Comparative evaluation of Akinesia and Anaesthesia
ISPUB.COM The Internet Journal of Anesthesiology Volume 18 Number 2 Single Injection versus Double Injection Peribulbar Anaesthesia in Eye Camp Surgery: a Comparative P Singh, A Jadon, B Singh Citation
More informationBotulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease
528 Western Eye Hospital, Marylebone Road, London NW1 JMOlver Accepted for publication 19 November 1997 Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease Jane M Olver
More informationUsing a Vibration Device to Ease Pain During Facial Needling and Injection
Using a Vibration Device to Ease Pain During Facial Needling and Injection Hiroaki Kuwahara, MD, a,b and Rei Ogawa, MDPhD b a Department of Plastic and Reconstructive Surgery Aidu-Chuo Hospital, Fukushima,
More informationOur Experience with Endoscopic Brow Lifts
Aesth. Plast. Surg. 24:90 96, 2000 DOI: 10.1007/s002660010017 2000 Springer-Verlag New York Inc. Our Experience with Endoscopic Brow Lifts Ozan Sozer, M.D., and Thomas M. Biggs, M.D. İstanbul, Turkey and
More informationLocal Anesthesia by Topical Application of Lidocaine After Stratum Corneum Ablation with an Er:YAG Laser
ISPUB.COM The Internet Journal of Anesthesiology Volume 6 Number 2 Local Anesthesia by Topical Application of Lidocaine After Stratum Corneum Ablation with an Er:YAG J Koh, D Harrison, S Flock, K Marchitto,
More informationComparison of Bier's Block and Systemic Analgesia for Upper Extremity Procedures: A Randomized Clinical Trial
J Arch Mil Med. 1 August; (3): e1977. Published online 1 August 3. DOI: 1.81/jamm.1977 Research Article Comparison of Bier's Block and Systemic Analgesia for Upper Extremity Procedures: A Randomized Clinical
More informationLocal Anesthetics in Cosmetic Dermatology. Peter W. Hashim, MD, MHS; John K. Nia, MD; Mark Taliercio, BS; Gary Goldenberg, MD
COSMETIC DERMATOLOGY Local Anesthetics in Peter W. Hashim, MD, MHS; John K. Nia, MD; Mark Taliercio, BS; Gary Goldenberg, MD PRACTICE POINTS The proper delivery of local anesthesia is integral to successful
More informationBotulinum Toxin Injections
KAISER PERMANENTE SAN FRANCISCO DEPARTMENT OF NEUROLOGY Office Procedures included: - Botulinum Toxin Injections - Electroencephalogram (EEG) - Electromyography (EMG) and Nerve Condition Studies (NCS)
More informationEACH year more than 10 million wounds are CLINICAL INVESTIGATIONS. LET versus EMLA for Pretreating Lacerations: A Randomized Trial
ACADEMIC EMERGENCY MEDICINE March 2001, Volume 8, Number 3 223 CLINICAL INVESTIGATIONS LET versus EMLA for Pretreating Lacerations: A Randomized Trial ADAM J. SINGER, MD, MARY JO STARK, RN Abstract. Objective:
More informationORIGINAL ARTICLE. Long-term Enhancement of Botulinum Toxin Injections by Upper-Eyelid Surgery in 14 Patients With Facial Dyskinesias
Long-term Enhancement of Botulinum Toxin Injections by Upper-Eyelid in 14 Patients With Facial Dyskinesias Joseph A. Mauriello, Jr, MD; Rohit Keswani; Mark Franklin ORIGINAL ARTICLE Objectives: To determine
More informationBotox , The Patient Education Institute, Inc. rxf60101 Last reviewed: 01/11/2018 1
Botox Introduction Botox is a well known brand name for a medicinal form of a toxin, or poison. When injected in small doses into specific muscles, Botox doesn't poison you. Instead, it acts as a muscle
More informationFrequently Asked Questions
1112:V15:05:PB1540 Frequently Asked Questions For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory Dear Doctor, Warm regards from Cipla Xterna!!! We, at Cipla Xterna, a dedicated
More informationEvaluation of the patient for cosmetic Botox injections
Facial Plast Surg Clin N Am 11 (2003) 349 358 Evaluation of the patient for cosmetic Botox injections Steven H. Dayan, MD, FACS*, Benjamin A. Bassichis, MD Department of Otolaryngology, Division of Facial
More informationPlease see Important Safety Information, including Boxed Warning, inside.
Sandra was treated in her frown lines and crow s feet areas. Results may vary. Please see Important Safety Information, including Boxed Warning, inside. Approved Uses BOTOX Cosmetic (onabotulinumtoxina)
More informationINFORMED CONSENT BOTOX INJECTION
. Purchasers of the Patient Consultation Resource Book are given a limited license to modify documents contained herein and reproduce the modified version for use in the Purchaser's own practice only.
More informationDexamethasone Improves Outcome Of Infraclavicular Brachial Plexus Block
Tanta Medical Journal Vol. (6), April 2008 Original Article ABSTRACT Dexamethasone Improves Outcome Of Infraclavicular Brachial Plexus Block Mohamed Samy Seddik Department of Anesthesia & Intensive Care,
More informationTITLE: Use of Topical Anesthetics for Suturing and Circumcisions in Pediatric Patients: A Review of Clinical Effectiveness and Guidelines
TITLE: Use of Topical Anesthetics for Suturing and Circumcisions in Pediatric Patients: A Review of Clinical Effectiveness and Guidelines DATE: 24 March 2009 CONTEXT AND POLICY ISSUES: Topical anesthetics
More informationCynthia was treated for her frown lines and crow s feet. Results may vary. Please see Important Safety Information, including Boxed Warning, inside.
Cynthia was treated for her frown lines and crow s feet. Results may vary. Please see Important Safety Information, including Boxed Warning, inside. Your lines don t define you Get the subtle results you
More informationSTUDY. Full-Face Laser Resurfacing Using a Supplemented Topical Anesthesia Protocol
STUDY Full-Face Laser Resurfacing Using a Supplemented Topical Anesthesia Protocol Suzanne L. Kilmer, MD; Vera Chotzen, MD; Brian D. Zelickson, MD; Marla McClaren, MD; Susan Silva, MD; Jacqueline Calkin,
More informationEFFICACY OF A SINGLE SUBCONJUNCTIVAL INJECTION WITH DISPORT FOR LID RETRACTION TREATMENT
Original Article EFFICACY OF A SINGLE SUBCONJUNCTIVAL INJECTION WITH DISPORT FOR LID RETRACTION TREATMENT Khataminia Gh R 1, Moosavian J 2 ABSTRACT Objective: To evaluate the safety and efficacy of dysport
More informationYou know you want to. Ask us today. Please see Important Safety Information, including Boxed Warning, inside.
You know you want to Ask us today. Please see Important Safety Information inside. 2016 Allergan. All rights reserved. All trademarks are the property of their respective owners. BotoxCosmetic.com 1-800-BOTOXMD
More informationPlease see Approved Uses and Important Safety Information, including Boxed Warning, inside.
Please see Approved Uses and Important Safety Information, including Boxed Warning, inside. IT S YOUR STORY, TELL IT YOUR WAY You ve probably heard of BOTOX Cosmetic, but did you know: It s the first and
More informationUse of Subcutaneous Local Anaesthetic in Venous Catheters Channelling For Reducing Pain. Pedro Raúl Castellano Santana 1
International Journal of Nursing December 2015, Vol. 2, No. 2, pp. 179-186 ISSN 2373-7662 (Print) 2373-7670 (Online) Copyright The Author(s). 2015. All Rights Reserved. Published by American Research Institute
More information200 SW 8 th St, STE A, Ocala, FL PH: FAX: Dr. Omar Garcia, Medical Director
200 SW 8 th St, STE A, Ocala, FL 34471 PH: 352-369-0104 FAX: 352-369-0107 Dr. Omar Garcia, Medical Director BRIEF MEDICAL HISTORY Name Phone Age Height Weight Address City State Zip Current Physician's
More informationClinical Summary. Introduction. What are Scars? There are three main types of scars:
Introduction Clinical Summary Since the introduction of silicone in the early 1980s for the prevention and treatment of hypertrophic & keloid scars, it s therapeutic effects have been well documented in
More informationSatisfaction of Patients After Treatment With Botulinum Toxin for Dynamic Facial Lines
Satisfaction of Patients After Treatment With Botulinum Toxin for Dynamic Facial Lines BORIS SOMMER, MD, n INA ZSCHOCKE, PHD, w DOROTHEE BERGFELD, MD, n GERHARD SATTLER, MD, n AND MATTHIAS AUGUSTIN, MD,PHD
More informationLong-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm
pissn: 111-8942 eissn: 292-9382 Korean J Ophthalmol 218;32(1):1-7 https://doi.org/1.3341/kjo.217.3 Original Article Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm Seunghyun
More informationTreat Your Patients Better
Treat Your Patients Better With Fractional Innovation Introducing For Skin Rejuvenation By Small Smart Systems Glabellar Frown Lines Crow s Feet (Peri-orbital Lines) Forehead worry lines Improves: Wrinkles
More informationExpert Approaches to Using Botulinum Toxins
FUNDACIÓN JAIME PLANAS ARTÍCULOS CIENTÍFICOS Expert Approaches to Using Botulinum Toxins Issue 2 Optimising Combination Therapy Authors: Dr Rafael Serena and Dr Artur Carbonell, Barcelona, Spain April
More informationDYSPORT (Clostridium botulinum type A toxin-haemagglutinin complex)
DYSPORT (Clostridium botulinum type A toxin-haemagglutinin complex) CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Dysport. It does not contain all
More informationFractional CO 2 Laser Skin Resurfacing for the Treatment of Sun-Damaged Skin and Actinic Keratoses COS DERM
Case Report Fractional CO 2 Laser Skin Resurfacing for the Treatment of Sun-Damaged Skin and Actinic Keratoses LindaSusan Marcus, MD; Neal Carlin, BS; Robert Carlin, BS, MA It is important to realize that
More informationCLINICAL EVALUATION REPORT ON THE EFFICACY AND SAFETY OF THE CORE SYSTEM FOR FACIAL ENHANCEMENT TREATMENTS
CLINICAL EVALUATION REPORT ON THE EFFICACY AND SAFETY OF THE CORE SYSTEM FOR FACIAL ENHANCEMENT TREATMENTS BACKGROUND Efforts to improve fractional ablative laser systems have led to the development of
More informationAnatomical Context of Facial Aesthetics Online CME Post-Test
progressive aesthetic learning essential to technical expertise Anatomical Context of Facial Aesthetics Online CME Post-Test Full Name: Degree: e-mail: May we contact you in approximately three months
More informationDYSPORT (Clostridium botulinum type A toxin-haemagglutinin complex)
DYSPORT (Clostridium botulinum type A toxin-haemagglutinin complex) CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Dysport. It does not contain all
More informationSupplementary Online Content
Supplementary Online Content Yu W, Jin Y, Yang J, et al. Occurrence of bruise, hematoma, and pain in upper blepharoplasty using blunt-needle vs sharp-needle anesthetic injection in upper blepharoplasty:
More informationBOTOX Cosmetic (onabotulinumtoxina) before-and-after
BOTOX Cosmetic (onabotulinumtoxina) before-and-after Moderate to severe crow s feet lines Before After (Day 7) Actual patient. Results may vary. Photos taken at full smile before and after treatment with
More informationPlease see Important Safety Information, including Boxed Warning, inside.
Sandra was treated in her frown lines and crow s feet areas. Results may vary. Please see Important Safety Information, including Boxed Warning, inside. Approved Uses BOTOX Cosmetic (onabotulinumtoxina)
More informationOriginal Article Surgical approach to limiting skin contracture following protractor myectomy for essential blepharospasm
Original Article Surgical approach to limiting skin contracture following protractor myectomy for essential blepharospasm Jeremy Clark, MD, a John Randolph, MD, a Jason A. Sokol, MD, b Nicholas A. Moore,
More informationTriamcinolone-Procaine in the Treatment of Zoster and Postzoster Neuralgia
Triamcinolone-Procaine in the Treatment of Zoster and Postzoster Neuralgia ERVIN EPSTEIN, M.D., Oakland * Twenty-four patients with herpes zoster were treated with injections of 2 percent procaine hydrochloride
More informationORIGINAL ARTICLE. Electromyographic Differences Between Normal Upper and Lower Facial Muscles and the Influence of Onabotulinum Toxin A
ORIGINAL ARTICLE Electromyographic Differences Between Normal Upper and Lower Facial Muscles and the Influence of Onabotulinum Toxin A Bryan J. Winn, MD; Bryan S. Sires, MD, PhD Importance: Empirically
More informationInternational consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) part I: upper facial wrinkles
DOI: 10.1111/j.1468-3083.2010.03631.x JEADV ORIGINAL ARTICLE International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) part I: upper facial wrinkles B Ascher,,
More informationTetsuji WAKUDA, Masanao SHIBASAKI,Tadashi TANITSU* National University Corporation, Tsukuba University of Technology *Cooperation with research
NTUT Education of Disabilities, 2009 Vol. 7 Effects of Acupuncture on Control of Pruritus Associated with Atopic Dermatitis Course in Acupuncture and Moxibustion, Department of Health, Tsukuba University
More informationidentifying & treating Structural Skin Damage
identifying & treating Structural Skin Damage How Collagen and Elastin are Formed The dermis is comprised of three layers: the papillary dermis, the reticular dermis, and the subcutaneous dermis. The process
More informationBOTOX Cosmetic (onabotulinumtoxina) before-and-after photo files
BOTOX Cosmetic (onabotulinumtoxina) before-and-after photo files INSTRUCTIONS FOR USE This zip file contains PDF files with images and Important Safety Information to copy and paste into your practice
More informationMANITOBA RENAL PROGRAM
SUBJECT Venipuncture of Arteriovenous Fistula/Graft MANITOBA RENAL PROGRAM SECTION CODE 30.20.01 30.20 Vascular Access AUTHORIZATION Professional Advisory Committee, Manitoba Renal Program Nursing Practice
More informationMANITOBA RENAL PROGRAM
SUBJECT Venipuncture of Arteriovenous Fistula/Graft MANITOBA RENAL PROGRAM SECTION CODE 30.30.01 30.30 Vascular Access AUTHORIZATION Professional Advisory Committee, Manitoba Renal Program Nursing Practice
More informationAntibody-Induced Failure of Botulinum Toxin A Therapy in Cosmetic Indications
Antibody-Induced Failure of Botulinum Toxin A Therapy in Cosmetic Indications DIRK DRESSLER, MD, PHD, KAI WOHLFAHRT, MD, PHD, y ELLEN MEYER-ROGGE, MD, z LUITGARD WIEST, MD, y AND HANS BIGALKE, MD, PHD
More informationUltrasound-guided supraclavicular brachial plexus nerve block vs procedural sedation for the treatment of upper extremity emergencies
American Journal of Emergency Medicine (2008) 26, 706 710 www.elsevier.com/locate/ajem Brief Report Ultrasound-guided supraclavicular brachial plexus nerve vs procedural for the treatment of upper extremity
More informationBotox Best Practices. Copyright, Legal Notice and Disclaimer. Published by: International Association for Physicians in Aesthetic Medicine (IAPAM)
Botox Best Practices Copyright, Legal Notice and Disclaimer This publication is protected under the US Copyright Act of 1976 and all other applicable international, federal, state and local laws, and all
More informationThe Beneficial Effects of Postrhinoplasty TapingFact or Fiction? Kyle A. Belek, MD, Ronald P. Gruber, MD
The Beneficial Effects of Postrhinoplasty TapingFact or Fiction? Kyle A. Belek, MD, Ronald P. Gruber, MD Rhinoplasty The Beneficial Effects of Postrhinoplasty Taping: Fact or Fiction? Kyle A. Belek, MD;
More informationBotulinum Neuromodulators: The Basics. Karol A Gutowski, MD, FACS
Botulinum Neuromodulators: The Basics Karol A Gutowski, MD, FACS Disclosures AxcelRx Pharmacuticals - Advisory Board Suneva Medical - Instructor Will discuss off-label uses Will use brand names for ease
More informationOverview of Botulinum Toxin
Chapter 1 Overview of Botulinum Toxin Berthold Rzany, Hendrik Zielke 1 Contents 1.1 Introduction............. 1 1.2 Different Subtypes of Botulinum Toxin. 1 1.3 Mode of Action............ 1 1.4 Antidote...............
More informationTHYROID EYE DISEASE ORBITAL DECOMPRESSION SURGERY
THYROID EYE DISEASE ORBITAL DECOMPRESSION SURGERY What is thyroid eye disease (TED)? TED is an autoimmune condition where the body s own immune system attacks the tissues of the thyroid gland and the eye
More informationComparative study of dermaroller therapy versus trichloroacetic acid CROSS for the treatment of atrophic acne scars
Original Article Comparative study of dermaroller therapy versus trichloroacetic acid CROSS for the treatment of atrophic acne scars Neerja Puri Consultant Dermatologist, Punjab Health Systems Corporation,
More informationComparison of EMLA and Diclofenac on Reduction of Pain and Phlebitis Caused by Peripheral IV Catheter: A Randomized-Controlled Trial Study
Wayne State University Nursing Faculty Research Publications Nursing 1-1-2019 Comparison of EMLA and Diclofenac on Reduction of Pain and Phlebitis Caused by Peripheral IV Catheter: A Randomized-Controlled
More informationCOMPARATIVE ANAESTHETIC PROPERTIES OF VARIOUS LOCAL ANAESTHETIC AGENTS IN EXTRADURAL BLOCK FOR LABOUR
Br.J. Anaesth. (1977), 49, 75 COMPARATIVE ANAESTHETIC PROPERTIES OF VARIOUS LOCAL ANAESTHETIC AGENTS IN EXTRADURAL BLOCK FOR LABOUR D. G. LITTLEWOOD, D. B. SCOTT, J. WILSON AND B. G. COVINO SUMMARY Various
More informationTreatment of Facial Palsy with Botulinum Toxin (Botox)
Treatment of Facial Palsy with Botulinum Toxin (Botox) You have been recommended treatment with Botulinum Toxin. This leaflet aims to explain the treatment, what to expect during the procedure and how
More informationASPIRE INFORMED CONSENT DOCUMENT
INSTRUCTIONS This is an informed- consent document that has been prepared to help inform you of your proposed surgery, its risks, as well as alternative treatments. It is important that you read this information
More informationBUTTONHOLE CANNULATION
BUTTONHOLE CANNULATION What is a Buttonhole? Technique in which an AV fistula is cannulated in the exact same spot, at the same angle and at the same depth of penetration every time. Benefits Reduction
More informationCONSENT FOR FACE-LIFT SURGERY (RHYTIDECTOMY)
CONSENT FOR FACE-LIFT SURGERY (RHYTIDECTOMY) Patient s Name Date Please initial each paragraph after reading. If you have any questions, please ask your doctor BEFORE initialing. I have been informed that
More informationTo successfully perform any facial injection,
INJECTABLES Newer Understanding of Specific Anatomic Targets in the Aging Face as Applied to Injectables: Facial Muscles Identifying Optimal Targets for Neuromodulators Jonathan M. Sykes, MD Patrick Trevidic,
More informationCrow's Feet Treatment with Botulinum Toxin Type A. I Petropoulos, G Noussios, P Chouridis, G Kontzoglou, K Karagiannidis
ISPUB.COM The Internet Journal of Aesthetic and Antiaging Medicine Volume 1 Number 2 Crow's Feet Treatment with Botulinum Toxin Type A I Petropoulos, G Noussios, P Chouridis, G Kontzoglou, K Karagiannidis
More informationBrachial plexus blockade within the interscalene groove involves local anesthetic
Interscalene Brachial Plexus Block- How I do it. Part 1 of a 2 part discussion on technique. Stuart Grant Professor of Anesthesiology Duke University Medical Center Durham NC Brachial plexus blockade within
More informationSuccessful IV Starts Revised February 2014
Successful IV Starts Revised February 2014 Why Intravenous Therapy? Used for access to the body s circulation Indications: Administer fluids, blood, medications, and nutrition Obtain laboratory specimens
More information